Übersicht unserer Publikationen

  • Müller, C., D.M. Tufa, D. Chatterjee, P.F. Mühlradt, R.E. Schmidt, and R. Jacobs. 2015. The TLR 2/6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker. Cancer Immunol. Immunother.: Volume 64, Issue 9, Page 1175-1184.
  • Chatterjee D, N. Marquardt, D.M. Tufa, T. Hatlapatka, R. Hass, C. Kasper, C. von Kaisenberg, R.E. Schmidt, and R. Jacobs. 2014. Human umbilical cord-derived mesenchymal stem cells utilize activin-A to suppress interferon-g production by natural killer cells. Front. Immunol. 5: 662.
  • Tufa DM, D. Chatterjee, H.Z. Low, R.E. Schmidt, and R. Jacobs. 2014. TNFR2 and IL-12 coactivation enables slanDCs to support NK cell function via membrane-bound TNF-a. Eur. J. Immunol. 44(12):3717-28.
  • Chatterjee D., N. Marquardt, D.M. Tufa, G. Beauclair, H.Z. Low, T. Hatlapatka, R. Hass, C. Kasper, C. von Kaisenberg, R.E. Schmidt, and R. Jacobs. 2014. Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity. Cell Commun Signal. 12(1):63.
  • Chatterjee, D., D.M. Tufa, H. Baehre, R. Hass, R.E. Schmidt, and R. Jacobs. 2014. Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells. Blood. 123:594–595.
  • Rahman, S.H., S. Bobis-Wozowicz, D. Chatterjee, K. Gellhaus, K. Pars, R. Heilbronn, R. Jacobs, and T. Cathomen. 2013. The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting. Hum Gene Ther. 2012/10/18:67–77. (joined publication with C9)
  • Daenthanasanmak, A., G. Salguero, S. Borchers, C. Figueiredo, R. Jacobs, B.S. Sundarasetty, A. Schneider, A. Schambach, B. Eiz-Vesper, R. Blasczyk, E.M. Weissinger, A. Ganser, and R. Stripecke. 2012. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo. Vaccine. 30:5118–31. (joined publication with A6)
  • Gabaev, I., L. Steinbrück, C. Pokoyski, A. Pich, R.J. Stanton, R. Schwinzer, T.F. Schulz, R. Jacobs, M. Messerle, and P.C. Kay-Fedorov. 2011. The Human Cytomegalovirus UL11 Protein Interacts with the Receptor Tyrosine Phosphatase CD45, Resulting in Functional Paralysis of T Cells. PLoS Pathog. 7:e1002432. (joined publication with B6)
  • Hass R, Kasper C, Bohm S, Jacobs R. 2011. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Communication and Signaling 9(1):12
  • Hatlapatka T., P. Moretti, P., A. Lavrentieva, R. Hass, N. Marquardt, R. Jacobs, and C. Kasper. 2011. Optimization of culture conditions for the expansion of umbilical cord derived MSC like cells using xeno-free culture conditions. Tissue Eng Part C Methods. 2011 Jan 19.
  • Steiner J, Marquardt N, Pauls I, Schiltz K, Rahmoune H, Bahn S, Bogerts B, Schmidt RE, Jacobs R. 2011. Human CD8+ T cells and NK cells express and secrete S100B upon stimulation. Brain Behav Immun 25(6):9.
  • Bhatnagar, N., H.S. Hong, J.K. Krishnaswamy, A. Haghikia, G.M. Behrens, R.E. Schmidt, and R. Jacobs. 2010. Cytokine-activated NK cells inhibit PMN apoptosis and preserve their functional capacity. Blood. 116:1308–16.
  • Marquardt, N., E. Wilk, C. Pokoyski, R.E. Schmidt, and R. Jacobs. 2010. Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population. Eur J Immunol. ;40(5):1428-39.
  • Wilk E., T. Witte, N. Marquardt, C. Hennig, G. Hansen, R.E. Schmidt, and R. Jacobs. 2010. Reply. Arthritis Rheum. 62(8):2563-2565.
  • Wilk E., T. Witte, N. Marquardt, T. Horvath, K. Kalippke, K. Scholz, N. Wilke, R.E. Schmidt, and R. Jacobs. 2009. Depletion of functionally active CD20+ T cells by rituximab treatment. Arthritis Rheum. 60(12):3563-3571